Insurance insights
Solvency II – be ready for 2013
Solvency II is the widest ranging regulatory reform that most people in the insurance industry have ever faced. By the time it comes into force, in January 2013, much work will have been done by insurance companies to ensure that all functions, including the investment department, are fully engaged.
Dirk Popielas, Managing Director for Insurance at J.P. Morgan Asset Management discusses the importance of Solvency II and the Quantitative Impact Study (QIS 5).
Solvency II and Emerging Markets Debt
In this paper, we examine the relevance of investment grade emerging markets debt (EMD IG) under Solvency II. In particular we compare it to the broader asset class and to various developed market European bond indices. Our analysis shows that combinations of corporate and government EMD IG offer an attractive investment opportunity for insurers operation under the Solvency II framework.
Solvency II and Money Market Funds
In this paper, we examine the treatment of money market funds under Solvency II, based on our interpretation of the technical specifications contained within the fifth published Quantitative Impact Studies. We believe that a well diversified money market fund is likely to produce a lower capital charge under Solvency II than direct cash investments.
Contact us
We would welcome the opportunity to meet with you to discuss your needs and challenges in the lead up to Solvency II. If you would like any further information, please contact us:
Philip Michaelsen
+44 (0)20 7777 0377
Neil Moge
+44 (0)20 7742 5879
The Insurance Insider Monte Carlo Capital Roundtable
Dirk Popielas, Head of Insurance EMEA and Matt Malloy, Head of Insurance North America, join a panel of industry experts for the Insurance Insider Capital roundtable 2011.